Tomas Cesak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tomas Cesak has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Filip Gabalec
University Hospital and Faculty of Medicine of Charles University in Hradec Kralove
4 shared publications - David Netuka
Department of Neurosurgery and Neurooncology Military University Hospital Prague Czech Republic
3 shared publications - Martin Beránek
Institute of Clinical Biochemistry and Diagnostics, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove, Czech Republic
3 shared publications - Václav Masopust
Department of Neurosurgery, First Faculty of Medicine, Central Military Hospital, Charles University, Prague, Czech Republic
3 shared publications - Jan Cap
4th Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital Hradec Kralove
2 shared publications - Jaroslav Adamkov
Charles University
2 shared publications
Latest Publications
- 28 February 2026
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 85 (9) , 992-1003
Unusual immunohistochemical profiles in hemangioblastomas and their relevance in differential diagnosis: A comprehensive study of 112 cases
Hemangioblastomas (HB) are rare CNS neoplasms. Their main differential diagnosis includes meningioma, glioma, and metastatic clear cell renal carcinoma. However, the diagnostic immunoprofile of HBs is only imprecisely defined. We analyzed a multicentric cohort of HBs using tissue microarrays and whole sections to determine immunoreactivities of a range of selected meningothelial, glial and other markers used in diagnostic pathology. The clinical and pathological features were correlated. The cohort included 112 tumors from 104 patients (46.1% males, 53.9% females) with a mean age 50.1 years. The tumors occurred in cerebellum (72%), spine (18.9%) and medulla oblongata (5.4%). No HB expressed SSTR2A, MUC4 or STAT6. Expression of glial markers S100, GFAP, Olig2, and SOX10 was observed in 93.3%, 80.6%, 5.1%, and 8.1% of cases, respectively. Inhibin-α was positive in 84.5% and carbonic anhydrase IX (CAIX) in 100% of the cases. Negative PAX8 immunostaining was observed using specific C-terminus antibody whereas N-terminus anti-PAX8 staining yielded 63.2% positivity. T-brachyury, SATB2, and GPNMB were observed in 3.8%, 2.1%, and 20.8%, respectively. No expression of SOX17, CDX2, Sall4, GATA3, or INSM1 was observed. Thus, HBs show a consistent PAX8-negative/CAIX-positive immunoprofile while they lack meningothelial markers and occasionally may express SOX10 and Olig2.
- 28 February 2026
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 85 (9) , 992-1003
Unusual immunohistochemical profiles in hemangioblastomas and their relevance in differential diagnosis: A comprehensive study of 112 cases
Hemangioblastomas (HB) are rare CNS neoplasms. Their main differential diagnosis includes meningioma, glioma, and metastatic clear cell renal carcinoma. However, the diagnostic immunoprofile of HBs is only imprecisely defined. We analyzed a multicentric cohort of HBs using tissue microarrays and whole sections to determine immunoreactivities of a range of selected meningothelial, glial and other markers used in diagnostic pathology. The clinical and pathological features were correlated. The cohort included 112 tumors from 104 patients (46.1% males, 53.9% females) with a mean age 50.1 years. The tumors occurred in cerebellum (72%), spine (18.9%) and medulla oblongata (5.4%). No HB expressed SSTR2A, MUC4 or STAT6. Expression of glial markers S100, GFAP, Olig2, and SOX10 was observed in 93.3%, 80.6%, 5.1%, and 8.1% of cases, respectively. Inhibin-α was positive in 84.5% and carbonic anhydrase IX (CAIX) in 100% of the cases. Negative PAX8 immunostaining was observed using specific C-terminus antibody whereas N-terminus anti-PAX8 staining yielded 63.2% positivity. T-brachyury, SATB2, and GPNMB were observed in 3.8%, 2.1%, and 20.8%, respectively. No expression of SOX17, CDX2, Sall4, GATA3, or INSM1 was observed. Thus, HBs show a consistent PAX8-negative/CAIX-positive immunoprofile while they lack meningothelial markers and occasionally may express SOX10 and Olig2.
- 16 August 2018
- Published by Springer Nature in Pituitary
- Vol. 21 (6) , 561-570
Medically induced CSF rhinorrhea following treatment of macroprolactinoma: case series and literature review
Although several reports have addressed cerebrospinal fluid (CSF) rhinorrhea following dopamine agonist (DA) therapy of macroprolactinomas, further study is warranted for this relatively uncommon entity. Toward this aim, our retrospective series and review of literature further clarifies recommendations in treatment of this rare problem.
- 16 August 2018
- Published by Springer Nature in Pituitary
- Vol. 21 (6) , 561-570
Medically induced CSF rhinorrhea following treatment of macroprolactinoma: case series and literature review
Although several reports have addressed cerebrospinal fluid (CSF) rhinorrhea following dopamine agonist (DA) therapy of macroprolactinomas, further study is warranted for this relatively uncommon entity. Toward this aim, our retrospective series and review of literature further clarifies recommendations in treatment of this rare problem.
- 30 September 2017
- Published by Care Comm in Česká a slovenská neurologie a neurochirurgie
- Vol. 80/113 (5) , 552-560
Thermal Management in Patients Undergoing Elective Spinal Surgery in Prone Position – a Prospective Randomized Trial
- 30 September 2017
- Published by Care Comm in Česká a slovenská neurologie a neurochirurgie
- Vol. 80/113 (5) , 552-560
Thermal Management in Patients Undergoing Elective Spinal Surgery in Prone Position – a Prospective Randomized Trial
- Open Access
- 24 June 2016
- Published by Palacky University Olomouc in Biomedical Papers
- Vol. 160 (2) , 238-243
Expression profiles of somatostatin, dopamine, and estrogen receptors in pituitary adenomas determined by means of synthetic multilocus calibrators
Aims: Pituitary adenomas (PA) are non-invasive benign tumors with a high autopsy prevalence. They are classified according to the type of hormone secreted (prolactin, growth hormone, adrenocorticotropin, thyrotropin, folitropin, or luteinizing...
- 24 June 2016
- Published by Palacky University Olomouc in Biomedical Papers
- Vol. 160 (2) , 238-243
Open AccessExpression profiles of somatostatin, dopamine, and estrogen receptors in pituitary adenomas determined by means of synthetic multilocus calibrators
Aims: Pituitary adenomas (PA) are non-invasive benign tumors with a high autopsy prevalence. They are classified according to the type of hormone secreted (prolactin, growth hormone, adrenocorticotropin, thyrotropin, folitropin, or luteinizing...
- 1 January 2015
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 27 (1) , 51-56
A Comparison of Equivolume, Equiosmolar Solutions of Hypertonic Saline and Mannitol for Brain Relaxation in Patients Undergoing Elective Intracranial Tumor Surgery
Hyperosmolar solutions have been used in neurosurgery to modify brain bulk and prevent neurological deterioration. The purpose of the study was to compare the effects of equivolume, equiosmolar solutions of mannitol and hypertonic saline (HTS) on brain relaxation and postoperative complications in patients undergoing elective intracranial tumor surgery. In this prospective, randomized study, patients with American Society of Anesthesiologists physical status I to III scheduled to undergo a craniotomy for intracranial tumors were enrolled. Patients received a 3.75 mL/kg intravenous infusion of either 3.2% HTS (group HTS, n=36) or 20% mannitol (group M, n=38). The surgeon assessed the condition of the brain using a 4-point scale after opening the dura. Recorded measures included duration of surgery, blood loss, urine output, volume and type of infused fluids, hemodynamic variables, electrolytes, glucose, creatinine, predefined postoperative complications, and length of intensive care unit and hospital stays. Brain relaxation conditions in group HTS (score 1/2/3/4, n=10/17/2/7) were better than those in group M (score 1/2/3/4, n=3/18/3/14, P=0.0281). Patients in group M had higher urine output, received more crystalloids during surgery, and displayed lower central venous pressure and lower natremia at the end of surgery than did patients in group HTS. No significant differences in postoperative complications or lengths of intensive care unit and hospital stays were observed between the groups. Our results suggest that HTS provides better brain relaxation than mannitol during elective intracranial tumor surgery.
- 1 January 2015
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 27 (1) , 51-56
A Comparison of Equivolume, Equiosmolar Solutions of Hypertonic Saline and Mannitol for Brain Relaxation in Patients Undergoing Elective Intracranial Tumor Surgery
Hyperosmolar solutions have been used in neurosurgery to modify brain bulk and prevent neurological deterioration. The purpose of the study was to compare the effects of equivolume, equiosmolar solutions of mannitol and hypertonic saline (HTS) on brain relaxation and postoperative complications in patients undergoing elective intracranial tumor surgery. In this prospective, randomized study, patients with American Society of Anesthesiologists physical status I to III scheduled to undergo a craniotomy for intracranial tumors were enrolled. Patients received a 3.75 mL/kg intravenous infusion of either 3.2% HTS (group HTS, n=36) or 20% mannitol (group M, n=38). The surgeon assessed the condition of the brain using a 4-point scale after opening the dura. Recorded measures included duration of surgery, blood loss, urine output, volume and type of infused fluids, hemodynamic variables, electrolytes, glucose, creatinine, predefined postoperative complications, and length of intensive care unit and hospital stays. Brain relaxation conditions in group HTS (score 1/2/3/4, n=10/17/2/7) were better than those in group M (score 1/2/3/4, n=3/18/3/14, P=0.0281). Patients in group M had higher urine output, received more crystalloids during surgery, and displayed lower central venous pressure and lower natremia at the end of surgery than did patients in group HTS. No significant differences in postoperative complications or lengths of intensive care unit and hospital stays were observed between the groups. Our results suggest that HTS provides better brain relaxation than mannitol during elective intracranial tumor surgery.
- 1 April 2013
- Published by Bioscientifica in Endocrine Abstracts
No correlation between somatostatine 2 receptor expression analyzed by RNAin-situhybridization and real-time qRT-PCR in clinically non-functioning pituitary adenomas
Objective: The aim of this study was to quantitatively estimate SSTR2 in clinically non-functioning pituitary adenomas (CNFAs) with use of RNA in-situ hybridization (ISH) and quantitative real-time RT-PCR and correlate the results of both methods. Methods: A standard histological and immunohistochemical examination was performed on the resected pituitary tumour. Afterwards in-situ hybridization for somatostatine 2 receptor (SSTR2) RNA was performed manually using the RNAscope® 2.0 FFPE Assay (Advanced Cell Diagnostics, Inc., Hayward, CA, USA) on formalin fixed and paraffin embedded tissue sections. Small part of the same tumour resected during operation and stored in RNAlater was used for quantitative real-time RT-PCR. Results: A 25 adenomas with SSTR2 mRNA expression in qRT-PCR were chosen for further evaluation with RNA ISH. SSTR2 mRNA was expressed in all adenomas from 1413–148 680 copies/5 μl cDNA; the median of relative quantity (after normalization to housekeeping gene GUS) for SSTR2 was 111%. In contrast to qRT-PCR immunostaining was positive only in nine adenomas with the use of RNA ISH. Positive cases were subsequently semi-quantitatively assessed according to the manufacturer’s scoring guideline as follows: 1 adenoma with 1+, 5 with 2+ and 3 with 3+. No adenoma scored 4+ although high expression of SSTR2 mRNA was present. We did not find any correlation between data (Spearman’s rank correlation coefficient 0.243). Conclusion: Use of somatostatine analogues or dopastatins remains controversial in CNFAs. Verification of SSTR presence before use of drug treatment should be useful. Both RNA ISH and qRT-PCR have their pitfalls. In our case, we did show no correlation between these methods. RNA ISH is definitely less sensitive and specific. We think that interpretation of results for SSTR2 expression in RNA ISH and qRT-PCR should be very careful. Project is supported by Ministry of Health Project No. NT/11344-4/2010.
- 1 April 2013
- Published by Bioscientifica in Endocrine Abstracts
No correlation between somatostatine 2 receptor expression analyzed by RNAin-situhybridization and real-time qRT-PCR in clinically non-functioning pituitary adenomas
Objective: The aim of this study was to quantitatively estimate SSTR2 in clinically non-functioning pituitary adenomas (CNFAs) with use of RNA in-situ hybridization (ISH) and quantitative real-time RT-PCR and correlate the results of both methods. Methods: A standard histological and immunohistochemical examination was performed on the resected pituitary tumour. Afterwards in-situ hybridization for somatostatine 2 receptor (SSTR2) RNA was performed manually using the RNAscope® 2.0 FFPE Assay (Advanced Cell Diagnostics, Inc., Hayward, CA, USA) on formalin fixed and paraffin embedded tissue sections. Small part of the same tumour resected during operation and stored in RNAlater was used for quantitative real-time RT-PCR. Results: A 25 adenomas with SSTR2 mRNA expression in qRT-PCR were chosen for further evaluation with RNA ISH. SSTR2 mRNA was expressed in all adenomas from 1413–148 680 copies/5 μl cDNA; the median of relative quantity (after normalization to housekeeping gene GUS) for SSTR2 was 111%. In contrast to qRT-PCR immunostaining was positive only in nine adenomas with the use of RNA ISH. Positive cases were subsequently semi-quantitatively assessed according to the manufacturer’s scoring guideline as follows: 1 adenoma with 1+, 5 with 2+ and 3 with 3+. No adenoma scored 4+ although high expression of SSTR2 mRNA was present. We did not find any correlation between data (Spearman’s rank correlation coefficient 0.243). Conclusion: Use of somatostatine analogues or dopastatins remains controversial in CNFAs. Verification of SSTR presence before use of drug treatment should be useful. Both RNA ISH and qRT-PCR have their pitfalls. In our case, we did show no correlation between these methods. RNA ISH is definitely less sensitive and specific. We think that interpretation of results for SSTR2 expression in RNA ISH and qRT-PCR should be very careful. Project is supported by Ministry of Health Project No. NT/11344-4/2010.
- 20 May 2011
- Published by Springer Nature in Pituitary
- Vol. 15 (2) , 222-226
Dopamine 2 receptor expression in various pathological types of clinically non-functioning pituitary adenomas
Clinically non-functioning pituitary adenomas account for about one-third of pituitary tumors. The majority of them are pathologically classified as gonadotropinomas or null-cell adenomas without hormonal expression. The rest represent silent corticotroph adenomas and plurihormonal tumors. Conservative therapy with dopamine agonists is effective in some cases only depending on the expression of dopamine 2 receptors (D2R). The aim of this study was to quantitatively estimate D2R expression in clinically non-functioning pituitary adenomas and correlate the results with adenoma type according to pathological classification. Out of the 87 adenomas investigated, 63 expressed gonadotropins, 7 were silent corticotroph adenomas, 7 were plurihormonal tumors, and only 6 did not express any pituitary hormone on immunohistochemical investigation. With the use of the reverse transcriptase PCR technique, D2R mRNA was expressed in all adenomas with very heterogeneous quantity. The expression was very low in corticotroph adenomas (relative median quantity after normalization to housekeeping gene 0.01) and lower in plurihormonal tumors (median 0.4) than in gonadotroph (median 1.3) and null-cell adenomas (median 1.9). The difference between corticotroph adenomas and plurihormonal tumors in comparison with other pathological types was statistically significant. The expression of D2R did not depend on the presence or absence of gonadotropins. We conclude that D2R expression is very low in corticotroph adenomas and significantly lower in plurihormonal tumors. The positivity of gonadotropins does not predict the D2R quantity.
- 20 May 2011
- Published by Springer Nature in Pituitary
- Vol. 15 (2) , 222-226
Dopamine 2 receptor expression in various pathological types of clinically non-functioning pituitary adenomas
Clinically non-functioning pituitary adenomas account for about one-third of pituitary tumors. The majority of them are pathologically classified as gonadotropinomas or null-cell adenomas without hormonal expression. The rest represent silent corticotroph adenomas and plurihormonal tumors. Conservative therapy with dopamine agonists is effective in some cases only depending on the expression of dopamine 2 receptors (D2R). The aim of this study was to quantitatively estimate D2R expression in clinically non-functioning pituitary adenomas and correlate the results with adenoma type according to pathological classification. Out of the 87 adenomas investigated, 63 expressed gonadotropins, 7 were silent corticotroph adenomas, 7 were plurihormonal tumors, and only 6 did not express any pituitary hormone on immunohistochemical investigation. With the use of the reverse transcriptase PCR technique, D2R mRNA was expressed in all adenomas with very heterogeneous quantity. The expression was very low in corticotroph adenomas (relative median quantity after normalization to housekeeping gene 0.01) and lower in plurihormonal tumors (median 0.4) than in gonadotroph (median 1.3) and null-cell adenomas (median 1.9). The difference between corticotroph adenomas and plurihormonal tumors in comparison with other pathological types was statistically significant. The expression of D2R did not depend on the presence or absence of gonadotropins. We conclude that D2R expression is very low in corticotroph adenomas and significantly lower in plurihormonal tumors. The positivity of gonadotropins does not predict the D2R quantity.
- 1 January 2009
- Published by AEPress, s.r.o. in Neoplasma
- Vol. 56 (1) , 84-87
Diagnosis and surgical therapy of plasma cell neoplasia of the spine
Diagnosis and surgical therapy of plasma cell neoplasia of the spine
- 1 January 2009
- Published by AEPress, s.r.o. in Neoplasma
- Vol. 56 (1) , 84-87
Diagnosis and surgical therapy of plasma cell neoplasia of the spine
Diagnosis and surgical therapy of plasma cell neoplasia of the spine
- 1 August 2004
- Published by Elsevier in Gynecologic Oncology
- Vol. 94 (2) , 267-276
Brain metastases of epithelial ovarian carcinoma responding to cisplatin and gemcitabine combination chemotherapy: a case report and review of the literature
- 1 August 2004
- Published by Elsevier in Gynecologic Oncology
- Vol. 94 (2) , 267-276
Brain metastases of epithelial ovarian carcinoma responding to cisplatin and gemcitabine combination chemotherapy: a case report and review of the literature